gastro news test
endocrinology news test 2
endocrinology news test
cardiology news test 2
cardiology news test
FDA approves weight management drug for patients aged 12 and older
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese, as defined by specific body mass index (BMI) cut-offs for age and sex that correspond to a BMI 30 kg/m2 or higher for adults,...
Lokelma drug quiz
PARSABIV (etelcalcetide)
Adverse reactions reported in ≥ 5% of Parsabiv®-treated patients1 Combined placebo-controlled substances *Included adverse reactions reported with at least 1% greater incidence in the Parsabiv® group compared to the placebo group. †Asymptomatic reductions in...